Bernal-Rusiel, J. L., Greve, D. N., Reuter, M., Fischl, B. & Sabuncu, M. R. Statistical analysis of longitudinal neuroimage data with linear mixed effects models. Neuroimage 66, 249–260 (2013).
Cespedes, M. I. et al. Comparisons of neurodegeneration over time between healthy ageing and Alzheimer’s disease cohorts via Bayesian inference. BMJ Open 7, e012174 (2017).
Ziegler, G., Penny, W. D., Ridgway, G. R., Ourselin, S. & Friston, K. J. Estimating anatomical trajectories with Bayesian mixed-effects modeling. Neuroimage 121, 51–68 (2015).
Bliese, P. D. Within-Group Agreement, Non-independence, and Reliability: Implications for Data Aggregation and Analysis (ScienceOpen, 2000).
Guerrero, R. et al. Instantiated mixed effects modeling of Alzheimer’s disease markers. Neuroimage 142, 113–125 (2016).
Rivera-Lares, K., Logie, R., Baddeley, A. & Della Sala, S. Rate of forgetting is independent of initial degree of learning. Mem. Cognit. https://doi.org/10.3758/s13421-021-01271-1 (2022).
Kieser, M., Friede, T. & Gondan, M. Assessment of statistical significance and clinical relevance. Stat. Med. 32, 1707–1719 (2013).
Van Rijn, M. H. C., Bech, A., Bouyer, J. & Van Den Brand, J. A. J. G. Statistical significance versus clinical relevance. Nephrol. Dial. Transplant. 32, 6–12 (2017).
Aksman, L. M. et al. Modeling longitudinal imaging biomarkers with parametric Bayesian multi-task learning. Hum. Brain Mapp. 40, 3982–4000 (2019).
Temp, A. G. M. et al. How Bayesian statistics may help answer some of the controversial questions in clinical research on Alzheimer’s disease. Alzheimer’s Dement. 17, 917–919 (2021).
Lesaffre, E. & Lawson, A. B. Bayesian Biostatistics (Wiley, 2012).
Wilkinson, M. Distinguishing between statistical significance and practical/clinical meaningfulness using statistical inference. Sports Med. 44, 295–301 (2014).
Hespanhol, L., Vallio, C. S., Costa, L. M. & Saragiotto, B. T. Understanding and interpreting confidence and credible intervals around effect estimates. Braz. J. Phys. Ther. 23, 290–301 (2019).
Berry, D. A. Bayesian clinical trials. Nat. Rev. Drug Discov. 5, 27–36 (2006).
Gurrin, L. C., Kurinczuk, J. J. & Burton, P. R. Bayesian statistics in medical research: An intuitive alternative to conventional data analysis. J. Eval. Clin. Pract. 6, 193–204 (2000).
van de Schoot, R., Winter, S. D., Ryan, O., Zondervan-Zwijnenburg, M. & Depaoli, S. A systematic review of Bayesian articles in psychology: The last 25 years. Psychol. Methods 22, 217–239 (2017).
Wagenmakers, E. J. et al. Bayesian inference for psychology. Part I: Theoretical advantages and practical ramifications. Psychon. Bull. Rev. 25, 35–57 (2018).
Jack, C. R. et al. Tracking pathophysiological processes in Alzheimer’s disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207–216 (2013).
Hardy, J. Amyloid, the presenilins and Alzheimer’s disease. Trends Neurosci. 20, 154–159 (1997).
Jack, C. R. et al. NIA-AA research framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement. 14, 535–562 (2018).
Petersen, R. C. et al. Alzheimer’s disease neuroimaging Initiative (ADNI): Clinical characterization. Neurology 74, 201–209 (2010).
Caroli, A. & Frisoni, G. B. The dynamics of Alzheimer’s disease biomarkers in the Alzheimer’s Disease Neuroimaging Initiative cohort. Neurobiol. Aging 31, 1263–1274 (2010).
Dickerson, B. C. et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease. Neurobiol. Aging 22, 747–754 (2001).
Jack, C. R. et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55, 484–489 (2000).
Schuff, N. et al. MRI of hippocampal volume loss in early Alzheimers disease in relation to ApoE genotype and biomarkers. Brain 132, 1067–1077 (2009).
Zhang, L. et al. Longitudinal trajectory of Amyloid-related hippocampal subfield atrophy in nondemented elderly. Hum. Brain Mapp. 41, 2037–2047 (2020).
Reuter, M., Schmansky, N. J., Rosas, H. D. & Fischl, B. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 61, 1402–1418 (2012).
Landau, S. & Jagust, W. Florbetapir Processing Methods (2015).
Buckner, R. L. et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: Reliability and validation against manual measurement of total intracranial volume. Neuroimage 23, 724–738 (2004).
Jack, C. R. et al. Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology 70, 1740–1752 (2008).
Fitzmaurice, G. M., Laird, N. M. & Ware, J. H. Applied Longitudinal Analysis (Wiley, 2011).
Satterthwaite, F. E. An approximate distribution of estimates of variance components. Biometr. Bull. 2, 110 (1946).
Morey, R. D., Hoekstra, R., Rouder, J. N., Lee, M. D. & Wagenmakers, E. J. The fallacy of placing confidence in confidence intervals. Psychon. Bull. Rev. 23, 103–123 (2016).
Bates, D., Mächler, M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 201–210 (2015).
Team, S. D. RStan: The R interface to Sta (2020).
Sorensen, T., Hohenstein, S. & Vasishth, S. Bayesian linear mixed models using Stan: A tutorial for psychologists, linguists, and cognitive scientists. Quant. Methods Psychol. 12, 175–200 (2015).
Hubbard, R. Corrupt Research: The Case for Reconceptualizing Empirical Management and Social Science (SAGE, 2016). https://doi.org/10.4135/9781506305332.
Ziliak, S. & McCloskey, D. The Cult of Statistical Significance: How the Standard Error Costs Us Jobs, Justice, and Lives (University of Michigan Press, 2008).
Pocock, S. J. & Hughes, M. D. Estimation issues in clinical trials and overviews. Stat. Med. 9, 657–671 (1990).
Li, D. et al. Bayesian latent time joint mixed-effects model of progression in the Alzheimer’s disease neuroimaging initiative. Alzheimer’s Dement. Diagn. Assess. Dis. Monit. 10, 657–668 (2018).
Staffaroni, A. M. et al. Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials. Brain 142, 443–459 (2019).
McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 7, 263–269 (2011).
Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 7, 270–279 (2011).